Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham J Mann

Showing results (41-50 of 183) with videos related to

Pageof 19
Sort By:
BMC Psychology|July 14, 2015
The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary diseaseMbathio Dieng, Nadine A Kasparian, Rachael L Morton, et al.
International Journal of Cancer|July 1, 2014
Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein informationKaushala Jayawardana, Sarah-Jane Schramm, Lauren Haydu, et al.
Applied Health Economics and Health Policy|January 7, 2018
A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in AustraliaCaroline G Watts, Sally Wortley, Sarah Norris, et al.
BMJ Open|February 12, 2021
Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic reviewZachary Blood, Anh Tran, Lauren Caleo, et al.
Clinical Pharmacology and Therapeutics|January 8, 2005
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancerMark Wong, Scott Evans, Laurent P Rivory, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 29, 2016
"Melanoma: Questions and Answers." Development and evaluation of a psycho-educational resource for people with a history of melanomaNadine A Kasparian, Shab Mireskandari, Phyllis N Butow, et al.
International Journal of Cancer|February 24, 2018
Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysisUpekha E Liyanage, Matthew H Law, Jue Sheng Ong, et al.
Proteomics. Clinical Applications|December 12, 2017
A 14-Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic MelanomaErin K Sykes, Cassandra E McDonald, Shila Ghazanfar, et al.
Breast Cancer Research : BCR|August 19, 2007
BCoR-L1 variation and breast cancerFelicity Lose, Jeremy Arnold, David B Young, et al.
ANZ Journal of Surgery|January 9, 2021
Prevalence of asymptomatic SARS-CoV-2 infection in elective surgical patients in Australia: a prospective surveillance studyNicholas Coatsworth, Paul S Myles, Graham J Mann, et al.
Pageof 19

Showing results (41-50 of 183) with videos related to

Sort By:
Pageof 19
BMC Psychology|July 14, 2015
The Melanoma care study: protocol of a randomised controlled trial of a psycho-educational intervention for melanoma survivors at high risk of developing new primary diseaseMbathio Dieng, Nadine A Kasparian, Rachael L Morton, et al.
International Journal of Cancer|July 1, 2014
Determination of prognosis in metastatic melanoma through integration of clinico-pathologic, mutation, mRNA, microRNA, and protein informationKaushala Jayawardana, Sarah-Jane Schramm, Lauren Haydu, et al.
Applied Health Economics and Health Policy|January 7, 2018
A National Budget Impact Analysis of a Specialised Surveillance Programme for Individuals at Very High Risk of Melanoma in AustraliaCaroline G Watts, Sally Wortley, Sarah Norris, et al.
BMJ Open|February 12, 2021
Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic reviewZachary Blood, Anh Tran, Lauren Caleo, et al.
Clinical Pharmacology and Therapeutics|January 8, 2005
Hepatic technetium Tc 99m-labeled sestamibi elimination rate and ABCB1 (MDR1) genotype as indicators of ABCB1 (P-glycoprotein) activity in patients with cancerMark Wong, Scott Evans, Laurent P Rivory, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 29, 2016
"Melanoma: Questions and Answers." Development and evaluation of a psycho-educational resource for people with a history of melanomaNadine A Kasparian, Shab Mireskandari, Phyllis N Butow, et al.
International Journal of Cancer|February 24, 2018
Polyunsaturated fatty acids and risk of melanoma: A Mendelian randomisation analysisUpekha E Liyanage, Matthew H Law, Jue Sheng Ong, et al.
Proteomics. Clinical Applications|December 12, 2017
A 14-Protein Signature for Rapid Identification of Poor Prognosis Stage III Metastatic MelanomaErin K Sykes, Cassandra E McDonald, Shila Ghazanfar, et al.
Breast Cancer Research : BCR|August 19, 2007
BCoR-L1 variation and breast cancerFelicity Lose, Jeremy Arnold, David B Young, et al.
ANZ Journal of Surgery|January 9, 2021
Prevalence of asymptomatic SARS-CoV-2 infection in elective surgical patients in Australia: a prospective surveillance studyNicholas Coatsworth, Paul S Myles, Graham J Mann, et al.
Pageof 19